Skip to main content
SpringerLink
Log in

Alemtuzumab

Acquired haemophilia A: 2 case reports.

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Comini-Frota ER, et al. Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases. Multiple Sclerosis and Related Disorders 44: 102181, Sep 2020. Available from: URL: http://doi.org/10.1016/j.msard.2020.102181

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 1813, 16 (2020). https://doi.org/10.1007/s40278-020-80773-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80773-0

Search

Navigation